Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis (IPF)

Study acronym: MAA
StatusActive, Not Recruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv20
  2. Study Status, Oversight, Outcome Measuresv19
  3. Re-verified, no change to tracked fieldsv18
  4. Primary and study completion dates: Jul 2025 to Jul 2030v17
  5. 3 versions Re-verified since Sep 15, 2020, no change to tracked fieldsv14-v16
Show 12 earlier versionsHide 12 earlier versions
  1. Primary and study completion dates: Jul 2020 to Jul 2025
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 150 to confirmed 80
    • Site details revised
    v13
  2. 2 versions Re-verified since Jul 24, 2017, no change to tracked fieldsv11-v12
  3. Site contact updatedv10
  4. Enrollment target: 100 to 150
    • Primary and study completion dates: Jul 2015 to Jul 2020
    • Site contact updated
    v9
  5. Site contact updatedv8
  6. Primary completion date: Jul 2015
    • Study completion date: Jul 2010 to Jul 2015
    • Site contact updated
    v7
  7. Re-verified, no change to tracked fieldsv6
  8. Enrollment target: 500 to 100
    • Study title expanded, about 3 words
    v5
  9. Enrollment target: 50 to 500
    • Study completion date: Apr 2007 to Jul 2010
    • Eligibility criteria revised
    • Site contact updated
    v4
  10. Study completion date: Apr 2007
    • Site contact updated
    v3
  11. Site contact updatedv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is investigating the way the lung is damaged in a condition called pulmonary fibrosis. Research studies will be conducted on lung tissue obtained from an open lung biopsy performed by the subject's surgeon. The identification of unique genetic markers of scarred lung may ultimately lead to new approaches to the diagnosis and treatment of pulmonary fibrosis.
Trial Details
NCT Number NCT00258544
Lead Sponsor University of Pittsburgh
Conditions
(from sponsor)		 Pulmonary Fibrosis
Related terms Fibrosis, Pulmonary Fibrosis
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov